Nifty slips below 14,400; breadth negative

Capital Market 

Key benchmark indices reversed early gains and hit fresh intraday low in morning trade. Rising COVID-19 cases continue to weigh on investors' sentiment. At 10:30 IST, the barometer index, the S&P BSE Sensex, was down 371.43 points or 0.77% at 48,172.49. The Nifty 50 index declined 105 points or 0.73% at 14,399.95.

In the broader market, the S&P BSE Mid-Cap index fell 1.28% while the S&P BSE Small-Cap index was down 1.11%.

The market breadth turned negative. On the BSE, 751 shares rose and 1687 shares fell. A total of 119 shares were unchanged.

COVID-19 Update:

Total COVID-19 confirmed cases worldwide stood at 138,056,297 with 2,971,539 deaths.

India reported 14,71,877 active cases of COVID-19 infection and 173,123 deaths while 124,29,564 patients have been discharged, according to the data from the Ministry of Health and Family Welfare, Government of India.

India on Wednesday reported 2,00,739 new COVID-19 cases and 1,038 deaths in last 24 hours, according to data from the Union Health Ministry.

Result Today:

IT major Wipro (up 2.85%) will announce its quarterly result today.

Buzzing Index:

The Nifty Pharma index added 1.2% to 12,960.85, snapping its two day losing streak. The index has slipped 1.45% in two days.

Cipla (up 3%), Cadila Healthcare (up 1.93%), Torrent Pharmaceutical (up 1.64%), Dr. Reddy's (up 1.24%), Sun Pharmaceutical (up 1.21%) and Aurobindo Pharma (up 1.07%) were major gainers.

Earnings Impact:

Infosys dropped 3.66%. On a consolidated basis, Infosys reported 2.3% decline in net profit to Rs 5,076 crore on 1.5% increase in revenues to Rs 26,311 crore in Q4 March 2021 over Q3 December 2020. The company's consolidated net profit rose 17.5% and revenues rose 13.1% in Q4 March 2021 over Q4 March 2020. In its outlook for FY22, Infosys has guided for 12% to 14% sales growth in constant currency terms in 2021-22 and an operating margin band of 22% to 24%.

The company reported 15.2% voluntary attrition rate for the quarter ended 31 March. It was 10% during the October-December quarter, Infosys said in the regulatory filing. The total number of employees at Bengaluru-based company stood at over 2.59 lakh as on 31 March, 2021.

Tata Metaliks fell 2.43% to Rs 881.10 after the company posted a 2.7% decline in net profit to Rs 74.99 crore in Q4 March 2021 from Rs 77 crore posted in Q4 March 2020. Net sales rose 26.7% to Rs 660.87 crore in Q4 March 2021 from Rs 521.60 crore registered in Q4 March 2020. Profit before tax increased by 28.5% year on year to Rs 123.73 crore in Q4 March 2021 over Q4 March 2020.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, April 15 2021. 10:31 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU